Related Experiment Videos
Risk prognosis correlation of insulin-like growth factor binding protein-3 and insulin-like growth factor-1 in
Tingting Lin1, Keke Qian1, Yanping Chen1
1The People's Hospital of Pingyang, Department of Gynaecology, Wenzhou City, China.
Background:
To explore the relationships between the levels of serum insulin-like growth factor binding protein-3 (IGFBP-3) and insulin-like growth factor 1 (IGF-1) and immune factors, as well as the prognosis of patients with uterine fibroids.
Methods:
The study group consisted of 186 patients with uterine fibroids who had laparoscopic myomectomy between June 2023 and June 2024, whereas the control group consisted of 208 healthy women who had physical tests over the same time period. The patients in the study group were divided into a good prognosis group (84 patients) and a poor prognosis group (92 patients). The levels of GFBP-3, IGF-1 and immune factors in the study group and the control group, and their relationships with prognosis were analysed.
Results:
Ten patients left the study group, and eight left the control group. IGFBP-3 and IGF-1 in the study group were (3 03.18± 42.39) mg/L and (1377.11 ± 84.78) mg/L, which both outperformed those in the control contingent [(231.2 5 ± 3 4 .1 8) mg/L and (4 3 8 .0 9 ± 5 2 .1 5) mg/L] (t= 12.87, 19.63) P< 0.001). Whereas the levels of CD3+, CD 4+, and CD 4+/CD 8+ were lower than those in the control group (t= 7.92, 8.41, 5.21, P< 0.001). Both values were higher [(284.63± 36.19) mg/L and (4 34.91± 53.28) mg/L]. P<0.001 (t= 5.96, 64.19). While the numbers of CD 3+, CD 4+, and CD 4+/CD 8+ cells were lower than those in the good prognosis group (t= 5.31, 7.03, 3.15). There was a positive correlation between CD8+ status and IGFBP-3, as well as history of uterine fibroids, number of fibroids, history of miscarriage, and duration of breastfeeding (r= 0.593, 0.452, 0.446, 0.419, 0.422, respectively). IGF-1 was negatively correlated with CD 3+, CD 4+, and CD 4+/CD 8+ (r=-0.720, -0.751, and -0.712, respectively). IGF-1 was positively correlated with CD8+ status, history of uterine fibroids, number of fibroids, history of miscarriage, and duration of breastfeeding (r= 0.631, 0.503, 0.444, 0.501, 0.451). The number of fibroids, a history of miscarriage, and the length of breastfeeding were risk variables that impacted the prognosis of patients with uterine fibroids.
Conclusions:
The levels of IGFBP-3, IGF-1 and CD-8+ in patients with uterine fibroids are relatively high. Moreover, IGFBP-3 and IGF-1 are related to immune factors and patient prognosis.